Hendrix College: Dr. John Byrd '87 and Dr. Tom Goodwin Credited With Early Work on Cancer Drug Recently Approved for Clinical Trials
October 15, 2024
October 15, 2024
CONWAY, Arkansas, Oct. 15 (TNSres) -- Hendrix College issued the following news release:
One of the biggest challenges in cancer treatment is finding ways to kill cancer cells without destroying healthy cells in the process. A drug newly approved for phase I/II clinical trials aims to achieve just that, and the roots of its discovery extend from Ohio to Arkansas -- specifically, Hendrix College.
A news release (https://cancer.osu.edu/news/ohio-state-drug-discovery-enter . . .
One of the biggest challenges in cancer treatment is finding ways to kill cancer cells without destroying healthy cells in the process. A drug newly approved for phase I/II clinical trials aims to achieve just that, and the roots of its discovery extend from Ohio to Arkansas -- specifically, Hendrix College.
A news release (https://cancer.osu.edu/news/ohio-state-drug-discovery-enter . . .